Values of ATX in predicting disease progression in patients with PBC and PBC related HCC.
10.3760/cma.j.cn501113-20221014-00496
- Author:
M Y ZHANG
1
;
H XIE
2
;
J ZHAO
2
;
Q S LIANG
2
;
L HAN
2
;
X R ZHAI
3
;
B S LI
2
;
Z S ZOU
2
;
Y SUN
2
Author Information
1. Graduate School of PLA General Hospital, Beijing 100853 Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039.
2. Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039.
3. Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing 100039 Peking University 302 Clinical Medical School, Beijing 100039.
- Publication Type:Journal Article
- Keywords:
Autotaxin;
Hepatocellular carcinoma;
Primary biliary cholangitis
- From:
Chinese Journal of Hepatology
2023;31(6):40-46
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To clarify the values of autotaxin (ATX) in patients with primary biliary cholangitis (PBC) and PBC-related hepatocellular carcinoma (HCC). Methods: 179 patients with PBC were selected from prospective cohorts of autoimmune liver diseases at the time of first diagnosis of PBC in Department of Hepatology, the Fifth Medical Center of PLA General Hospital, from January 2016 to January 2018, all patients with PBC received UDCA therapy, primary endpoint was event of HCC, the follow-up period was censored at the date of HCC. The relationship between level of ATX and clinical features in patients with PBC and its potential value in predicting disease progression and PBC-related HCC were analyzed. Results: The ATX level in the peripheral blood of patients with PBC was significantly higher than that of alcoholic liver cirrhosis(ALC) (t = 3.278, P = 0.001) and healthy controls(HC) (t = 6.594, P < 0.001), however, when comparing PBC to non-PBC related HCC, no significant difference was found between the groups(t=-0.240, P = 0.811). Consistent with peripheral blood levels, histochemical staining indicated that ATX in the liver of patients with PBC was significantly higher than that of HC (Z=-3.633, P < 0.001) and ALC (Z=-3.283, P < 0.001), and the expression of ATX in PBC with advanced histological stage was significantly higher than PBC with early stage (Z=-2.018, P = 0.034). The baseline ATX level in PBC patients without developing to HCC during follow-up had significant difference to patients with developing to HCC (228.451 ± 124.093 ng/ml vs 301.583 ± 100.512 ng/ml, t = 2.339, P = 0.021). The result in multivariate logistic regression analysis showed that ATX were independent predictors of PBC related HCC(OR 1.245, 95%CI 1.097-1.413). The optimal critical value of peripheral blood ATX level at baseline for predicting HCC was 235.254 ng/ml, with the cut-off value of 0.714 in AUC of the ROC (95% CI was 0.597~ 0.857), sensitivity and specificity were 84.6% and 59.0%, respectively. Conclusion: ATX level was significantly higher in PBC patients over controls, and it's concentration was correlated with UDCA efficacy and fibrosis stage. ATX has potential values in predicting disease progression and PBC-related HCC.
